David Fubini - Bain Capital Independent Director
| BCSF Stock | USD 17.12 0.19 1.12% |
Director
Mr. David G. Fubini is Independent Director of the Company. He has served on our Board since July 2016. Mr. Fubini is a Senior Lecturer in the Organizational Behavior Unit at Harvard Business School. Previously, he was a Senior Partner of McKinsey Company where he worked for over 34 years. He was McKinsey Managing Director of the Boston office, and the past leader of the North American Organization Practice as well as the founder and leader of the firm Worldwide Merger Integration Practice. During his tenure, Mr. Fubini led, andor had been a member of, many firm personnel committees, as well as a participant in a wide crosssection of McKinsey governance forums and committees. Prior to joining McKinsey, he was an initial member of a small group that became the McNeil Consumer Products Company of Johnson Johnson and helped launch the Tylenol family of products into the overthecounter consumer marketplace since 2016.
| Age | 67 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 200 Clarendon Street, Boston, MA, United States, 02116 |
| Phone | 617 516 2000 |
| Web | https://www.baincapitalspecialtyfinance.com |
David Fubini Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Fubini against Bain Capital stock is an integral part of due diligence when investing in Bain Capital. David Fubini insider activity provides valuable insight into whether Bain Capital is net buyers or sellers over its current business cycle. Note, Bain Capital insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bain Capital'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Fubini over six months ago Disposition of 7874 shares by David Fubini of Leidos Holdings at 127.8853 subject to Rule 16b-3 |
Bain Capital Management Efficiency
The company has return on total asset (ROA) of 0.0522 % which means that it generated a profit of $0.0522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1126 %, meaning that it created $0.1126 on every $100 dollars invested by stockholders. Bain Capital's management efficiency ratios could be used to measure how well Bain Capital manages its routine affairs as well as how well it operates its assets and liabilities. The Bain Capital's current Return On Tangible Assets is estimated to increase to 0.05. The Bain Capital's current Return On Capital Employed is estimated to increase to 0.1. At this time, Bain Capital's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Bain Capital's current Return On Assets is estimated to increase to 0.05, while Net Tangible Assets are projected to decrease to roughly 930.6 M.Similar Executives
| Found 11 records | DIRECTOR Age | ||
| Richard Higginbotham | Sixth Street Specialty | 72 | |
| Ronald Tanemura | Sixth Street Specialty | 56 | |
| Gilbert Ahye | Triplepoint Venture Growth | 72 | |
| Stephen Cassani | Triplepoint Venture Growth | 53 | |
| Steven Bird | Triplepoint Venture Growth | 65 | |
| Hugh Young | Abrdn Emerging Markets | 66 | |
| John Ross | Sixth Street Specialty | 74 | |
| Hurley Doddy | Sixth Street Specialty | 56 | |
| Catherine Dunn | New Mountain Finance | N/A | |
| Diana Thomas | New Mountain Finance | N/A | |
| George Catrambone | DWS Municipal Income | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0522 |
Bain Capital Specialty Leadership Team
Elected by the shareholders, the Bain Capital's board of directors comprises two types of representatives: Bain Capital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bain. The board's role is to monitor Bain Capital's management team and ensure that shareholders' interests are well served. Bain Capital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bain Capital's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Hough, Independent Director | ||
| Sally Dornaus, Chief Financial Officer | ||
| Michael Boyle, Vice President Treasurer | ||
| Jay Margolis, Independent Director | ||
| James Goldman, Chief Compliance Officer | ||
| David Fubini, Independent Director | ||
| Jessica Yeager, Secretary | ||
| Jeffrey Hawkins, Chairman of the Board | ||
| Michael Treisman, Vice President Secretary | ||
| Derek Kirby, Investor Contact | ||
| Clare Richer, Independent Director | ||
| Amy Butte, Independent Director | ||
| Katherine Schneider, Investor Officer | ||
| Michael Ewald, Chief Executive Officer, Director | ||
| Amit Joshi, Chief Officer |
Bain Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bain Capital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0522 | ||||
| Profit Margin | 0.44 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 2.38 B | ||||
| Shares Outstanding | 64.56 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 50.37 % | ||||
| Number Of Shares Shorted | 372.34 K | ||||
| Price To Earning | 10.38 X |
Currently Active Assets on Macroaxis
When determining whether Bain Capital Specialty is a strong investment it is important to analyze Bain Capital's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bain Capital's future performance. For an informed investment choice regarding Bain Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bain Capital Specialty. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bain Capital. If investors know Bain will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bain Capital listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.02) | Dividend Share 1.68 | Earnings Share 1.99 | Revenue Per Share 4.558 | Quarterly Revenue Growth 0.002 |
The market value of Bain Capital Specialty is measured differently than its book value, which is the value of Bain that is recorded on the company's balance sheet. Investors also form their own opinion of Bain Capital's value that differs from its market value or its book value, called intrinsic value, which is Bain Capital's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bain Capital's market value can be influenced by many factors that don't directly affect Bain Capital's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bain Capital's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bain Capital is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bain Capital's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.